Carregando...
Parental and Other Factors Associated with Hydroxyurea Use for Pediatric Sickle Cell Disease
BACKGROUND: Hydroxyurea (HU) is highly effective treatment for Sickle Cell Disease (SCD). While pediatric use of HU is accepted clinical practice, barriers to use may impede its potential benefit. PROCEDURE: A survey of parents of children ages 5–17 years with SCD was performed across five instituti...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3625668/ https://ncbi.nlm.nih.gov/pubmed/23129068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24381 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|